Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02778087 · ClinicalTrials.gov registry record · NA

Mirror Therapy After Stroke: A Dosing Study

A NA study, sponsored by Columbia University.

Terminated
Registry status
NA
Development phase
8
Enrollment target

NCT02778087 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 8 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02778087, a NA study, was terminated before completion, sponsored by Columbia University.

TERMINATED
Registry status
NA
Development phase
8 participants
Enrollment target

Study Summary

It has been suggested that augmenting repetitive task practice with the use of box (mirror) therapy (BT) can enhance the benefits of task practice and may provide stroke survivors an opportunity to engage in self-directed practice outside of normally scheduled therapy sessions. However, the dosage of BT to be used in clinical practice is unclear. In order for practitioners to begin integrating BT into clinical practice situations more information is needed to determine what defines a therapeutic dose. The aim of this study is to differentiate between two dosages of self-directed BT added to treatment as usual for decreasing arm and hand motor impairments, improving activity level, and increasing self-directed participation after stroke. Forty-five subjects from the Stroke Rehabilitation Unit at Helen Hayes Hospital (HHH) will be randomly assigned into three groups: treatment as usual plus 30 minute dosage of self-directed BT 5x/week; treatment as usual plus 60 minute dosage of self-directed BT 5x/week; treatment as usual plus 30 minutes of self-directed sham BT 5x/week.

Interventions

  • BEHAVIORAL Mirror Box Therapy
  • BEHAVIORAL Sham Mirror Box Therapy

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2017-01
Est. Completion 2018-02-13
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT02778087

The ClinicalTrials.gov registry entry for NCT02778087 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Mirror Box Therapy is the first listed.

NCT02778087 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02778087 about?

NCT02778087 is a clinical study titled "Mirror Therapy After Stroke: A Dosing Study". It has been suggested that augmenting repetitive task practice with the use of box (mirror) therapy (BT) can enhance the benefits of task practice and may provide stroke survivors an opportunity to engage in self-directed practice outside of normally scheduled therapy sessions. However, the dosage o...

What is the current status of trial NCT02778087?

This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2017-01. Estimated completion is 2018-02-13.

What interventions are being tested in trial NCT02778087?

The interventions under investigation include: Mirror Box Therapy (BEHAVIORAL), Sham Mirror Box Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02778087?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.